What we're reading, June 15, 2016: opioids also linked to heart-related deaths and fatalities other than overdoses; judge overrules Federal Trade Commission's efforts to block merger of Advocate Health Care and NorthShore University HealthSystem in Illinois; and using social media to monitor patients outside of the healthcare setting.
Opioids may also be linked to heart-related deaths and other fatalities in addition to overdose deaths. According to the AP, a study found that while 64% of patients taking opioids had a higher risk of dying within 6 months of starting their medication, only 18% of deaths were due to unintentional overdoses. The prescription painkillers are responsible for slowing breathing or worsening the type of disrupted breathing that occurs with sleep apnea, ultimately resulting in heart attacks or death.
In Illinois, a federal judge has overruled efforts by the Federal Trade Commission (FTC) to block a merger of 2 hospital systems. The FTC was interested in preventing the deal because it felt the system emerging as a result of the merger of Advocate Health Care and NorthShore University HealthSystem would dominate the North Shore area of Chicago, reported The New York Times. The judge’s reasoning has not been explained yet, but his decision will be released after the hospital systems can redact sensitive competitive information.
Doctors could start using social media to follow patients’ health issues. FastCompany reported that people are using social media to discuss health issues they normally don’t tell their doctors, which providers can use to monitor patients outside of a healthcare setting. However, few health systems are currently equipped to eal with remote patient monitoring.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More